There’s no shortage of competition on the Covid-19 vaccine market, and things aren’t made easier for Danish biotech firm Bavarian Nordic by competitors being some of the biggest players in the world – remaining so even after a year and some time since the first vaccines against Covid-19 hit the market.
Last week, Bavarian Nordic publicized phase II data on its candidate, ABNCoV2, reporting generally positive news. Should everything go according to plan, the firm should have an approved vaccine, backed by the Danish government, ready for the market in 2023.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Sales Manager Denmark 
Product specialist 
Clinical Project Lead 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Senior CMC & Device Project Manager 
Manager of QA, BHS Logistics 
eTMF Manager 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Scientist Radiochemistry 
CMC Writer 
Chief Business Officer 
Process Supporter working with SAP 
Vice President, Medical Affairs 
Senior/lead consultant at Emendo Engineering 
Senior CMC Regulatory Manager 
Lab Manager